These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 37951571)
1. Omalizumab improves sinonasal outcomes in patients with chronic rhinosinusitis with nasal polyps regardless of allergic status. Gevaert P; Mullol J; Saenz R; Ko J; Steinke JW; Millette LA; Meltzer EO Ann Allergy Asthma Immunol; 2024 Mar; 132(3):355-362.e1. PubMed ID: 37951571 [TBL] [Abstract][Full Text] [Related]
2. Defining the Efficacy of Omalizumab in Nasal Polyposis: A POLYP 1 and POLYP 2 Subgroup Analysis. Damask C; Chen M; Holweg CTJ; Yoo B; Millette LA; Franzese C Am J Rhinol Allergy; 2022 Jan; 36(1):135-141. PubMed ID: 34382434 [TBL] [Abstract][Full Text] [Related]
3. The Efficacy of Omalizumab in Patients with Chronic Rhinosinusitis with Nasal Polyps and Comorbid Severe Allergic Asthma. Atayik E; Aytekin G; Aydin İ; Omeroglu E Iran J Allergy Asthma Immunol; 2024 May; 23(3):245-256. PubMed ID: 39422385 [TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of omalizumab in nasal polyposis: 2 randomized phase 3 trials. Gevaert P; Omachi TA; Corren J; Mullol J; Han J; Lee SE; Kaufman D; Ligueros-Saylan M; Howard M; Zhu R; Owen R; Wong K; Islam L; Bachert C J Allergy Clin Immunol; 2020 Sep; 146(3):595-605. PubMed ID: 32524991 [TBL] [Abstract][Full Text] [Related]
5. Efficacy of dupilumab on chronic rhinosinusitis with nasal polyps and concomitant asthma in biologic-naive and biologic-pretreated patients. Domínguez-Sosa MS; Cabrera-Ramírez MS; Marrero-Ramos MDC; Dávila-Quintana D; Cabrera-López C; González Cuervo H; Benítez Del Rosario JJ; Carrillo-Díaz T Ann Med; 2024 Dec; 56(1):2411018. PubMed ID: 39364704 [TBL] [Abstract][Full Text] [Related]
6. Efficacy and Safety of Dupilumab Versus Omalizumab in Chronic Rhinosinusitis With Nasal Polyps and Asthma: EVEREST Trial Design. De Prado Gomez PharmD MSc L; Khan Mbbs Mph AH; Peters Md AT; Bachert Md PhD C; Wagenmann Md M; Heffler Md PhD E; Hopkins BMBCh C; Hellings Md PhD PW; Zhang PhD M; Xing PhD J; Rowe Md P; Jacob-Nara Md Mph DHSc JA Am J Rhinol Allergy; 2022 Nov; 36(6):788-795. PubMed ID: 35837739 [TBL] [Abstract][Full Text] [Related]
7. [A real world study of anti-IgE monoclonal antibody in the treatment of allergic united airway disease]. Sui HJ; Zhen Z; Wang QG; Cong TC; Huang JJ; Hu Y Zhonghua Yu Fang Yi Xue Za Zhi; 2023 Feb; 57(2):273-280. PubMed ID: 36797588 [No Abstract] [Full Text] [Related]
8. Long-term efficacy and safety of omalizumab for nasal polyposis in an open-label extension study. Gevaert P; Saenz R; Corren J; Han JK; Mullol J; Lee SE; Ow RA; Zhao R; Howard M; Wong K; Islam L; Ligueros-Saylan M; Omachi TA; Bachert C J Allergy Clin Immunol; 2022 Mar; 149(3):957-965.e3. PubMed ID: 34530020 [TBL] [Abstract][Full Text] [Related]
9. Omalizumab improves sleep and health status for patients with chronic rhinosinusitis with nasal polyps: An analysis of randomized clinical trials. Meltzer EO; Mullol J; Ko J; Saenz R; Steinke JW; Millette LA; Gevaert P Int Forum Allergy Rhinol; 2024 Jul; 14(7):1163-1172. PubMed ID: 38197558 [TBL] [Abstract][Full Text] [Related]
10. Effects of Omalizumab Treatment in Patients With Recalcitrant Nasal Polyposis and Mild Asthma: A Multicenter Retrospective Study. Armengot-Carceller M; Gómez-Gómez MJ; García-Navalón C; Doménech-Campos E; Muñoz-Fernández N; Miguel AG; Marco-Algarra J; Palop-Cervera M; Piñero AG Am J Rhinol Allergy; 2021 Jul; 35(4):516-524. PubMed ID: 33153272 [TBL] [Abstract][Full Text] [Related]
11. Omalizumab treats chronic rhinosinusitis with nasal polyps and asthma together-a real life study. Bidder T; Sahota J; Rennie C; Lund VJ; Robinson DS; Kariyawasam HH Rhinology; 2018 Mar; 56(1):42-45. PubMed ID: 29288573 [TBL] [Abstract][Full Text] [Related]
13. Doxycycline may be more clinically effective in type 2 chronic rhinosinusitis nasal polyp comorbid with asthma. Paçacı Çetin G; Arslan B; Yılmaz İ J Asthma; 2024 Jan; 61(1):20-26. PubMed ID: 37437223 [TBL] [Abstract][Full Text] [Related]
14. Chronic Rhinosinusitis with Nasal Polyps: Targeting IgE with Anti-IgE Omalizumab Therapy. Kariyawasam HH; James LK Drug Des Devel Ther; 2020; 14():5483-5494. PubMed ID: 33328726 [TBL] [Abstract][Full Text] [Related]
15. [Short-term efficacy of anti-IgE monoclonal antibody in patients with recurrent chronic rhinosinusitis with nasal polyps combined with asthma]. Shen S; Lou HF; Yan B; Wang Y; Cao FF; Xiong W; Wang CS; Zhang L Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2021 Oct; 56(10):1035-1041. PubMed ID: 34666463 [No Abstract] [Full Text] [Related]
16. The Effectiveness of Biological Agents on Chronic Rhinosinusitis with Nasal Polyposis in Patients with Comorbid Asthma: A Multicenter Real-Life Study from Türkiye. Demir M; Tunakan Dalgic C; Mete Gokmen EN; Savas R; Eroglu S; Ozden G; Orcen C; Pacaci Cetin G; Arslan B; Bilgir F; Bulut G; Akcam NY; Ozgul S; Cerci P; Coskun R; Gode S; Yilmaz I; Sin AZ Medicina (Kaunas); 2024 Mar; 60(3):. PubMed ID: 38541174 [No Abstract] [Full Text] [Related]
17. IgE directly affects eosinophil migration in chronic rhinosinusitis with nasal polyps through CCR3 and predicts the efficacy of omalizumab. Yu J; Yan B; Shen S; Wang Y; Li Y; Cao F; Xiong W; Piao Y; Hu C; Sun Y; Zhang L; Wang C J Allergy Clin Immunol; 2024 Feb; 153(2):447-460.e9. PubMed ID: 37922997 [TBL] [Abstract][Full Text] [Related]
18. Biologic Therapies for Allergic Rhinitis and Nasal Polyposis. Geng B; Dilley M; Anterasian C Curr Allergy Asthma Rep; 2021 Jun; 21(6):36. PubMed ID: 34110505 [TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of switching between biologics in chronic rhinosinusitis with nasal polyps or N-ERD. Brkic FF; Liu DT; Klimbacher R; Campion NJ; Bartosik TJ; Vyskocil E; Stanek V; Tu A; Arnoldner T; Bangert C; Gangl K; Eckl-Dorna J; Schneider S Rhinology; 2023 Aug; 61(4):320-327. PubMed ID: 37515811 [TBL] [Abstract][Full Text] [Related]
20. Omalizumab Treatment in Uncontrolled Asthma and CRSwNP Patients, with Previous Endoscopic Sinus Surgery, to Improve Quality of Life and Endoscopic Outcomes: a Two-Year Real-Life Study. Maza-Solano J; Callejon-Leblic A; Martin-Jimenez D; Moreno-Luna R; Gonzalez-Garcia J; Cuvillo A; Sanchez-Gomez S Curr Allergy Asthma Rep; 2023 Oct; 23(10):555-566. PubMed ID: 37644255 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]